FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
The newly FDA-approved nasal spray called Spravato is being manufactured by Johnson & Johnson's and is a standalone treatment ...
The FDA approved Johnson & Johnson's Spravato, a ketamine-based nasal spray, to treat adults with major depressive disorder ...
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
New licensing rules mandate compliance with Schedule TB for ASU nasal sprays for patient safety: Shardul Nautiyal, Mumbai Friday, January 24, 2025, 08:00 Hrs [IST] The Union minis ...
VMPL New Delhi [India] January 22 Allergy season can be a challenging time for many with symptoms such as sneezing a runny ...
“With the global nasal spray market projected to reach over $23 billion by 2029 ... CDMO offers a powerful network of companies across Europe, North America and India that provide comprehensive, ...